Search research articles
Contact Us
Filters
Showing results (701-710 of 842) with videos related to
Page
of 85
Sort By:
Lancet (London, England)
|
September 4, 2016
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
Andreas Goette, Jose L Merino, Michael D Ezekowitz, et al.
American Heart Journal
|
March 18, 2020
Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation
Frederik Dalgaard, Rebecca North, Karen Pieper, et al.
JAMA
|
August 23, 2017
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
G Michael Felker, Kevin J Anstrom, Kirkwood F Adams, et al.
Circulation. Heart Failure
|
May 18, 2019
Rationale and Design of the VITALITY-HFpEF Trial
Javed Butler, Carolyn S P Lam, Kevin J Anstrom, et al.
JAMA Cardiology
|
July 4, 2019
Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation
Sean D Pokorney, DaJuanicia N Holmes, Laine Thomas, et al.
American Heart Journal
|
August 25, 2015
Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models
Prateeti Khazanie, Gretchen M Heizer, Vic Hasselblad, et al.
American Heart Journal
|
August 25, 2015
Diuretic response in acute heart failure-an analysis from ASCEND-HF
Jozine M ter Maaten, Allison M Dunning, Mattia A E Valente, et al.
ESC Heart Failure
|
August 4, 2017
Differentiating heart failure phenotypes using sex-specific transcriptomic and proteomic biomarker panels
Mustafa Toma, George J Mak, Virginia Chen, et al.
JACC. Heart Failure
|
October 31, 2025
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart Failure
James E Udelson, Jan Bělohlávek, Andrej Dukát, et al.
European Journal of Heart Failure
|
March 3, 2022
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction
Clara Saldarriaga, Dan Atar, Amanda Stebbins, et al.
Page
of 85
Search research articles
Search
Showing results (701-710 of 842) with videos related to
Sort By:
Page
of 85
Lancet (London, England)
|
September 4, 2016
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
Andreas Goette, Jose L Merino, Michael D Ezekowitz, et al.
American Heart Journal
|
March 18, 2020
Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation
Frederik Dalgaard, Rebecca North, Karen Pieper, et al.
JAMA
|
August 23, 2017
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
G Michael Felker, Kevin J Anstrom, Kirkwood F Adams, et al.
Circulation. Heart Failure
|
May 18, 2019
Rationale and Design of the VITALITY-HFpEF Trial
Javed Butler, Carolyn S P Lam, Kevin J Anstrom, et al.
JAMA Cardiology
|
July 4, 2019
Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation
Sean D Pokorney, DaJuanicia N Holmes, Laine Thomas, et al.
American Heart Journal
|
August 25, 2015
Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models
Prateeti Khazanie, Gretchen M Heizer, Vic Hasselblad, et al.
American Heart Journal
|
August 25, 2015
Diuretic response in acute heart failure-an analysis from ASCEND-HF
Jozine M ter Maaten, Allison M Dunning, Mattia A E Valente, et al.
ESC Heart Failure
|
August 4, 2017
Differentiating heart failure phenotypes using sex-specific transcriptomic and proteomic biomarker panels
Mustafa Toma, George J Mak, Virginia Chen, et al.
JACC. Heart Failure
|
October 31, 2025
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart Failure
James E Udelson, Jan Bělohlávek, Andrej Dukát, et al.
European Journal of Heart Failure
|
March 3, 2022
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction
Clara Saldarriaga, Dan Atar, Amanda Stebbins, et al.
Page
of 85